Targeting Src and Related Molecules to Inhibit Breast Cancer Growth
Author Information
Author(s): Bjorge Jeffrey D., Pang Andy S., Funnell Melanie, Chen Ke Yun, Diaz Roman, Magliocco Anthony M., Fujita Donald J.
Primary Institution: University of Calgary
Hypothesis
Can simultaneous siRNA targeting of Src and its downstream signaling partners inhibit tumor formation and metastasis in breast cancer?
Conclusion
Simultaneous targeting of Src and its downstream partners significantly inhibits tumor growth and metastasis in a breast cancer model.
Supporting Evidence
- siRNA targeting Src reduced Src protein levels by 62-67%.
- Simultaneous knock-down of Src and Stat3 or cMyc resulted in the greatest inhibition of tumor growth.
- Intra-tumoral injection of siRNAs significantly reduced tumor metastasis.
Takeaway
Scientists found that using special molecules called siRNAs to turn off certain genes can help stop breast cancer cells from growing and spreading.
Methodology
The study used siRNA to knock down Src and its partners in a breast cancer cell line and assessed tumor growth in mice.
Potential Biases
Potential bias in the selection of siRNA sequences and the specific cell line used.
Limitations
The study primarily focused on a single breast cancer cell line and may not generalize to all breast cancer types.
Participant Demographics
MDA-MB-435S breast cancer cell line, a widely used model for breast cancer research.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website